| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| SAP | 30 | 41 | +2,66 % | ||
| AIRBUS | 21 | 135 | +0,18 % | ||
| DEUTSCHE TELEKOM | 21 | 56 | +2,02 % | ||
| RHEINMETALL | 21 | 42 | -2,95 % | ||
| NOVO NORDISK | 21 | 40 | +0,22 % | ||
| ASTRAZENECA | 15 | 22 | +3,82 % | ||
| ASML | 13 | 26 | -0,15 % | ||
| INTESA SANPAOLO | 13 | 11 | +0,05 % | ||
| GSK | 10 | 64 | +2,87 % | ||
| RIO TINTO | 10 | 22 | +1,18 % |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05:10 | Uuups - was für ein Ausverkauf? Vola nutzen, mit Qualität eindecken! SAP, D-Wave und Aspermont im Fokus! | 368 | inv3st.de | In diesen Tagen herrscht wieder ordentlich Bewegung an den Märkten. Aufschwung hier, harter Rücksetzer dort! Die Volatilität ist zurück, angetrieben von politischen Statements und wirtschaftlichen Unwägbarkeiten.... ► Artikel lesen | |
| 04:38 | Deutsche Telekom Expands T Cloud Public into Fully Sovereign European Cloud | 3 | The Fast Mode | ||
| 04:38 | Viasat, Deutsche Telekom Extend In-Flight Connectivity Across Balkans | 3 | The Fast Mode | ||
| 03:30 | ASML CDR (CAD Hedged): ASML CDR (CAD Hedged) estimates dividend | 4 | Stockwatch | ||
| 03:17 | HSI Opens Up 220 Pts; Gold/Silver/Resource Stocks Rebound; HSBC HOLDINGS/NTES-S Rally | 2 | AASTOCKS | ||
| Mo | Banco Santander, S.A. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| Mo | RIO TINTO PLC - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| Mo | RIO TINTO LTD - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Mo | HSBC Physical Gold Trust - S-1, General form for registration of securities | 4 | SEC Filings | ||
| Mo | Genentech in up to $1.7B RNAi licensing deal with SanegeneBio | 4 | Seeking Alpha | ||
| Mo | IKEGPS GROUP LIMITED: SPH Notice - UBS Group AG and its related bodies corporate | 4 | NZX | ||
| Mo | Chevron cut at HSBC as position of strength already priced in | 5 | Seeking Alpha | ||
| Mo | GSK plans to lay off up to 350 R&D workers across US, UK | 7 | FierceBiotech | ||
| Mo | Novo's CagriSema tops semaglutide in ph. 3 diabetes study | 34 | FierceBiotech | ||
| Mo | RELX PLC - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Mo | Sanofi's venglustat demonstrates mixed results in late-stage rare disease trials | 10 | Seeking Alpha | ||
| Mo | Novo combination obesity shot meets goal in diabetes trial | 34 | BioPharma Dive | ||
| Mo | JPMORGAN stuft NOVO NORDISK auf 'Overweight' | 901 | dpa-AFX-Analyser | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Novo Nordisk auf "Overweight" mit einem Kursziel von 350 dänischen Kronen belassen. Laut Richard Vosser dürften Phase-III-Daten des Pharmakonzerns... ► Artikel lesen | |
| Mo | Nigerian insurer AXA Mansard's 2025 profit falls 79% as currency gains reverse | 6 | Ecofin Agency | ||
| Mo | Is Novo Nordisk Stock a Bargain Right Now? | 16 | The Motley Fool |